Page last updated: 2024-08-24

diphenylcyclopropenone and Recrudescence

diphenylcyclopropenone has been researched along with Recrudescence in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19901 (8.33)18.7374
1990's2 (16.67)18.2507
2000's0 (0.00)29.6817
2010's9 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choe, SJ; Keum, DI; Kim, BJ; Lee, CH; Lee, S; Lee, WS; Pi, LQ1
Kim, BJ; Lee, S; Lee, WS; Lee, YB1
Abdel-Raheem, HM; Azzam, OA; Bassiouny, DA; El-Zawahry, BM; Khorshied, MM; Zaki, NS1
Abbas, O; Abd-el-Baki, J; El Khoury, J; Kibbi, AG; Kurban, M; Succariah, F1
Lew, BL; Sim, WY; Suh, DW1
Li, B; Liu, J; Pan, R; Xuan, X1
Bergfeld, WF; Chiang, KS; Mesinkovska, NA; Piliang, MP1
Holmes, S; Lamb, RC; Young, D1
Alkhalifah, A; Alsantali, A; McElwee, KJ; Shapiro, J; Wang, E1
Buckley, DA; Du Vivier, AW; Fuller, LC; Higgins, EM; Keane, FM; Munn, SE1
Happle, R; Perret, CM; van Baar, HM; van der Steen, PH1
Douville, H; Orecchia, G; Rabbiosi, G; Santagostino, L1

Reviews

2 review(s) available for diphenylcyclopropenone and Recrudescence

ArticleYear
Hair Regrowth Outcomes of Contact Immunotherapy for Patients With Alopecia Areata: A Systematic Review and Meta-analysis.
    JAMA dermatology, 2018, 10-01, Volume: 154, Issue:10

    Topics: Adjuvants, Immunologic; Alopecia; Alopecia Areata; Cyclobutanes; Cyclopropanes; Hair; Humans; Immunotherapy; Recurrence

2018
Alopecia areata update: part II. Treatment.
    Journal of the American Academy of Dermatology, 2010, Volume: 62, Issue:2

    Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Alopecia Areata; Animals; Child; Cyclopropanes; Cyclosporine; Hair; Haptens; Humans; Immunotherapy; Injections, Intralesional; Laser Therapy; Methotrexate; Minoxidil; Photochemotherapy; Randomized Controlled Trials as Topic; Rats; Recurrence; Research Design; Social Support; Sulfasalazine; Treatment Outcome; Triamcinolone Acetonide

2010

Trials

1 trial(s) available for diphenylcyclopropenone and Recrudescence

ArticleYear
Treatment of alopecia areata with diphenylcyclopropenone.
    Journal of the American Academy of Dermatology, 1991, Volume: 24, Issue:2 Pt 1

    Topics: Administration, Topical; Alopecia Areata; Cyclopropanes; Dermatitis, Contact; Eczema; Humans; Immunotherapy; Recurrence

1991

Other Studies

9 other study(ies) available for diphenylcyclopropenone and Recrudescence

ArticleYear
Subclinical sensitization with diphenylcyclopropenone is sufficient for the treatment of alopecia areata: Retrospective analysis of 159 cases.
    Journal of the American Academy of Dermatology, 2018, Volume: 78, Issue:3

    Topics: Adolescent; Adult; Aged; Alopecia Areata; Cyclopropanes; Dermatologic Agents; Female; Hair; Humans; Immunotherapy; Male; Middle Aged; Recurrence; Retrospective Studies; Risk Factors; Treatment Outcome; Young Adult

2018
PTPN22 gene polymorphism in Egyptian alopecia areata patients and its impact on response to diphencyprone immunotherapy.
    Gene, 2013, Jul-10, Volume: 523, Issue:2

    Topics: Adolescent; Adult; Alleles; Alopecia Areata; Case-Control Studies; Cyclopropanes; Egypt; Female; Gene Frequency; Genotype; Humans; Immunotherapy; Male; Polymorphism, Single Nucleotide; Protein Tyrosine Phosphatase, Non-Receptor Type 22; Recurrence; Treatment Outcome; Young Adult

2013
Topical immunomodulation with diphenylcyclopropenone for alopecia areata: the Lebanese experience.
    International journal of dermatology, 2013, Volume: 52, Issue:12

    Topics: Adult; Alopecia Areata; Cyclopropanes; Female; Hair; Humans; Immunologic Factors; Lebanon; Male; Recurrence; Retrospective Studies; Treatment Outcome; Young Adult

2013
Investigations of the efficacy of diphenylcyclopropenone immunotherapy for the treatment of warts.
    International journal of dermatology, 2014, Volume: 53, Issue:12

    Topics: Adjuvants, Immunologic; Administration, Cutaneous; Adolescent; Adult; Child; Child, Preschool; Cyclopropanes; Female; Foot Dermatoses; Hand Dermatoses; Humans; Immunotherapy; Infant; Male; Recurrence; Time Factors; Warts; Young Adult

2014
Chinese experience in the treatment of alopecia areata with diphenylcyclopropenone.
    The Journal of dermatology, 2015, Volume: 42, Issue:2

    Topics: Administration, Cutaneous; Alopecia Areata; China; Cyclopropanes; Female; Humans; Male; Prognosis; Recurrence; Severity of Illness Index; Time Factors; Treatment Outcome

2015
Clinical Efficacy of Diphenylcyclopropenone in Alopecia Areata: Retrospective Data Analysis of 50 Patients.
    The journal of investigative dermatology. Symposium proceedings, 2015, Volume: 17, Issue:2

    Topics: Administration, Cutaneous; Adolescent; Adult; Alopecia; Alopecia Areata; Child; Cyclopropanes; Dermatologic Agents; Female; Hair; Humans; Male; Middle Aged; Recurrence; Retrospective Studies; Severity of Illness Index; Thyroid Diseases; Time Factors; Treatment Outcome; Young Adult

2015
Retrospective review of diphencyprone in the treatment of alopecia areata.
    Clinical and experimental dermatology, 2016, Volume: 41, Issue:4

    Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Aged; Alopecia Areata; Cyclopropanes; Eczema; Female; Hair; Headache; Humans; Hyperpigmentation; Immunotherapy; Lymphadenopathy; Male; Middle Aged; Recurrence; Retrospective Studies; Treatment Outcome

2016
Recalcitrant viral warts treated by diphencyprone immunotherapy.
    The British journal of dermatology, 1999, Volume: 141, Issue:2

    Topics: Adolescent; Adult; Aged; Child; Chronic Disease; Cyclopropanes; Female; Foot Dermatoses; Hand Dermatoses; Humans; Immunotherapy; Male; Middle Aged; Recurrence; Treatment Outcome; Warts

1999
Treatment of multiple relapsing warts with diphenciprone.
    Dermatologica, 1988, Volume: 177, Issue:4

    Topics: Adolescent; Adult; Child; Cyclopropanes; Female; Humans; Male; Middle Aged; Recurrence; Warts

1988